783 related articles for article (PubMed ID: 28710008)
1. Identifying synthetic lethal targets using CRISPR/Cas9 system.
Dhanjal JK; Radhakrishnan N; Sundar D
Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
[TBL] [Abstract][Full Text] [Related]
2. Validation of Synthetic CRISPR Reagents as a Tool for Arrayed Functional Genomic Screening.
Tan J; Martin SE
PLoS One; 2016; 11(12):e0168968. PubMed ID: 28030641
[TBL] [Abstract][Full Text] [Related]
3. High-throughput genetic screens using CRISPR-Cas9 system.
Kweon J; Kim Y
Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
[TBL] [Abstract][Full Text] [Related]
4. Synthetic Lethality and Cancer - Penetrance as the Major Barrier.
Ryan CJ; Bajrami I; Lord CJ
Trends Cancer; 2018 Oct; 4(10):671-683. PubMed ID: 30292351
[TBL] [Abstract][Full Text] [Related]
5. [High-throughput functional screening using CRISPR/Cas9 system].
Wang GC; Ming M; Ye YZ; Xi JZ
Yi Chuan; 2016 May; 38(5):391-401. PubMed ID: 27232487
[TBL] [Abstract][Full Text] [Related]
6. RNAi/CRISPR Screens: from a Pool to a Valid Hit.
Schuster A; Erasimus H; Fritah S; Nazarov PV; van Dyck E; Niclou SP; Golebiewska A
Trends Biotechnol; 2019 Jan; 37(1):38-55. PubMed ID: 30177380
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas-based customization of pooled CRISPR libraries.
Kweon J; Kim DE; Jang AH; Kim Y
PLoS One; 2018; 13(6):e0199473. PubMed ID: 29924860
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
Peng J; Zhou Y; Zhu S; Wei W
FEBS J; 2015 Jun; 282(11):2089-96. PubMed ID: 25731961
[TBL] [Abstract][Full Text] [Related]
9. Functional genomic screening approaches in mechanistic toxicology and potential future applications of CRISPR-Cas9.
Shen H; McHale CM; Smith MT; Zhang L
Mutat Res Rev Mutat Res; 2015; 764():31-42. PubMed ID: 26041264
[TBL] [Abstract][Full Text] [Related]
10. Identification of Synthetic Lethal Interactions Using High-Throughput, Arrayed CRISPR/Cas9-Based Platforms.
MacAuley MJ; Abuhussein O; Vizeacoumar FS
Methods Mol Biol; 2021; 2381():135-149. PubMed ID: 34590274
[TBL] [Abstract][Full Text] [Related]
11. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
Taylor J; Woodcock S
J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
[TBL] [Abstract][Full Text] [Related]
12. High-throughput functional genomics using CRISPR-Cas9.
Shalem O; Sanjana NE; Zhang F
Nat Rev Genet; 2015 May; 16(5):299-311. PubMed ID: 25854182
[TBL] [Abstract][Full Text] [Related]
13. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
Joung J; Konermann S; Gootenberg JS; Abudayyeh OO; Platt RJ; Brigham MD; Sanjana NE; Zhang F
Nat Protoc; 2017 Apr; 12(4):828-863. PubMed ID: 28333914
[TBL] [Abstract][Full Text] [Related]
14. A Novel Screening Approach for the Dissection of Cellular Regulatory Networks of NF-κB Using Arrayed CRISPR gRNA Libraries.
O'Shea P; Wildenhain J; Leveridge M; Revankar C; Yang JP; Bradley J; Firth M; Pilling J; Piper D; Chesnut J; Isherwood B
SLAS Discov; 2020 Jul; 25(6):618-633. PubMed ID: 32476557
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9 Toolkit for Actinomycete Genome Editing.
Tong Y; Robertsen HL; Blin K; Weber T; Lee SY
Methods Mol Biol; 2018; 1671():163-184. PubMed ID: 29170959
[TBL] [Abstract][Full Text] [Related]
16. A high-throughput screening strategy for detecting CRISPR-Cas9 induced mutations using next-generation sequencing.
Bell CC; Magor GW; Gillinder KR; Perkins AC
BMC Genomics; 2014 Nov; 15(1):1002. PubMed ID: 25409780
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 for cancer research and therapy.
Zhan T; Rindtorff N; Betge J; Ebert MP; Boutros M
Semin Cancer Biol; 2019 Apr; 55():106-119. PubMed ID: 29673923
[TBL] [Abstract][Full Text] [Related]
18. High-content analysis screening for cell cycle regulators using arrayed synthetic crRNA libraries.
Strezoska Ž; Perkett MR; Chou ET; Maksimova E; Anderson EM; McClelland S; Kelley ML; Vermeulen A; Smith AVB
J Biotechnol; 2017 Jun; 251():189-200. PubMed ID: 28445693
[TBL] [Abstract][Full Text] [Related]
19. Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting.
Iorio F; Behan FM; Gonçalves E; Bhosle SG; Chen E; Shepherd R; Beaver C; Ansari R; Pooley R; Wilkinson P; Harper S; Butler AP; Stronach EA; Saez-Rodriguez J; Yusa K; Garnett MJ
BMC Genomics; 2018 Aug; 19(1):604. PubMed ID: 30103702
[TBL] [Abstract][Full Text] [Related]
20. Pooled Lentiviral CRISPR-Cas9 Screens for Functional Genomics in Mammalian Cells.
Aregger M; Chandrashekhar M; Tong AHY; Chan K; Moffat J
Methods Mol Biol; 2019; 1869():169-188. PubMed ID: 30324523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
